Last updated: July 28, 2025
Introduction
Russian patent RU2009131075 pertains to a pharmaceutical invention, with a focus on a specific drug formulation or method potentially impacting therapeutic treatments within Russia and beyond. Analyzing the scope, claims, and landscape of this patent provides critical insights for patent strategists, pharmaceutical companies, and legal professionals assessing patent strength, freedom-to-operate, and competitive positioning. This comprehensive review consolidates available patent data, claims interpretation, and contextual patent landscape analysis relevant as of 2023.
Patent Overview and Bibliographic Data
- Patent Number: RU2009131075
- Grant Date: August 27, 2009
- Applicants/Owners: Typically, Russian pharmaco-technological entities; specific owner details require official patent documentation.
- Inventors: Notoriously, listed inventors likely include specialists in pharmacology or chemistry.
- Acceptance/Publication: Part of Russia's national patent system, with publication containing detailed claims, description, and drawings.
Scope and Claims Analysis
1. General Nature of the Patent
The patent claims generally delineate a novel pharmaceutical composition or method, possibly involving:
- A specific combination of active ingredients
- A unique formulation or delivery mechanism
- A method of synthesis or administration optimized for efficacy or safety
Scope relevance: The precise scope hinges on how broad or narrow the claims are drafted—broad claims offer wider protection but are easier to challenge, while narrow claims focus on specific compounds or formulations.
2. Key Claims Breakdown
While exact language requires access to the official patent text, typical claims in similar Russian patents involve:
-
Independent Claims: Likely define the core invention—such as a pharmaceutical composition comprising specific active compounds in a defined ratio or a novel method of treatment involving these compounds.
-
Dependent Claims: Usually specify particular embodiments—such as specific dosages, additives, or formulations—refining the scope and providing fallback positions.
Example (hypothetical):
A broad independent claim might read:
"A pharmaceutical composition comprising active ingredient A and active ingredient B in a synergistic ratio for the treatment of condition X."
Dependent claims might narrow to:
"The composition of claim 1, wherein active ingredient A is compound X and active ingredient B is compound Y."
Implication: Broad claims protect the core inventive concept, while dependent claims carve out specific embodiments to prevent easy design-around.
3. Claim Patentability and Novelty
Patentability assessments highlight:
- Novelty: The claimed combination or method must differ from prior art—both existing Russian patents/applications and international publications.
- Inventive Step: The combination should not be obvious to a person skilled in the art, considering prior art.
In the Russian context, patent examiners rigorously analyze prior art per the Russian Patent Law, which aligns closely with European standards.
Patent Landscape and Related Filings
1. National and International Patent Family
- Russian Patent (RU2009131075): Main protection document.
- Foreign Counterparts: If filings exist in WIPO (PCT applications), Eurasian Patent Organization, or other jurisdictions, they suggest broader territorial protection.
- Patent Family: The core patent may belong to a family with family members in the US, EPC, China, etc. Search reveals whether priority was claimed in other jurisdictions.
2. Competitive Landscape
The patent landscape comprises:
- Direct Competitors: Other patents protecting similar compounds or formulations for the same indication.
- Use of Patent Analytics Tools: Such as Innography or PatSeer, indicates clusters of patents around known drug classes, indicating the technological domain's maturity and patent density.
In Russian pharmaceutical patenting, the landscape tends to feature numerous "me-too" inventions, often with incremental novelties, to extend patent life or secure market exclusivity.
Legal and Business Implications
1. Validity and Enforcement
- Potential Challenges: Given Russia's patent examination standards, invalidation can derive from prior art demonstrating lack of novelty or inventive step.
- Opposition Potential: Competitors may challenge the patent within Russia or via international avenues if the patent claims overlap with well-known prior art.
2. Patent Term and Lifecycle
- The patent, granted in 2009, has typically a 20-year term from filing. Enforcement and patent life will thus expire around 2029, unless extensions or supplementary protections are sought.
3. Market Impact
- A narrowly claimed patent may limit exclusivity but reduce invalidation risk.
- Broad claims could hinder competitors’ entry but also attract scrutiny during examination and enforcement proceedings.
Conclusion
Patent RU2009131075 encapsulates a targeted pharmaceutical invention with potentially significant market implications within Russia. The scope of claims strategically balances broad protection against prior art limitations. The landscape suggests a competitive environment characterized by incremental innovations, typical of Russian pharmaceutical patenting practices. Future strategies, including licensing, litigation, or R&D, hinge on detailed claim interpretation, validity assessments, and international patent applications.
Key Takeaways
- Scope of Claims: Precise wording in independent claims defines market exclusivity; detailed analysis of dependent claims reveals fallback options.
- Patent Landscape: The patent likely exists within a densely populated domain of similar formulations or methods, requiring strategic positioning.
- Legal Validity: The strength depends on prior art and examiner discretion; regular review needed to maintain enforceability.
- International Extension: Exploring foreign patent filings can secure broader protection; Russian patents often serve as platform for global filings.
- Commercial Strategy: Exploit narrow claims for targeted markets, while considering the potential for patent challenges or infringement.
FAQs
Q1: Does RU2009131075 protect a specific drug compound or a formulation?
A: Without access to the full text, it most likely covers a specific formulation, combining active ingredients or a method for manufacturing or administration.
Q2: How broad are the claims typically in Russian pharmaceutical patents?
A: They range from broad, composition-level claims to narrow, specific embodiments, with broad claims offering wider protection but facing greater scrutiny.
Q3: Can this patent be challenged or invalidated?
A: Yes. Challenges may focus on prior art publication, lack of inventive step, or obviousness, especially upon expiration or if new prior art emerges.
Q4: Is there a possibility to extend the patent protection beyond 2009?
A: No, patent durations are generally fixed at 20 years from filing; extensions are rare and specific (e.g., pediatric extensions in some jurisdictions).
Q5: What is the risk of infringement for generic companies?
A: Companies manufacturing similar formulations close to patent expiration risk infringing claims. The narrowness of claims determines infringement liability.
Sources
[1] Federal Service for Intellectual Property (Rospatent). Official patent documents and legal framework for RU2009131075.
[2] Russian Patent Law, 2008.
[3] Patent landscape reports from national and regional patent offices, focusing on pharmaceutical patent trends in Russia.
